Annual SG&A
$42.08 M
-$708.00 K-1.65%
31 December 2023
Summary:
C4 Therapeutics annual selling, general & administrative expenses is currently $42.08 million, with the most recent change of -$708.00 thousand (-1.65%) on 31 December 2023. During the last 3 years, it has risen by +$26.88 million (+176.78%). CCCC annual SG&A is now -1.65% below its all-time high of $42.79 million, reached on 31 December 2022.CCCC Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$11.77 M
+$2.07 M+21.38%
30 September 2024
Summary:
C4 Therapeutics quarterly selling, general & administrative expenses is currently $11.77 million, with the most recent change of +$2.07 million (+21.38%) on 30 September 2024. Over the past year, it has increased by +$1.24 million (+11.73%). CCCC quarterly SG&A is now -8.21% below its all-time high of $12.82 million, reached on 31 March 2022.CCCC Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$2.26 B
-$105.50 M-4.90%
30 September 2024
Summary:
C4 Therapeutics TTM selling, general & administrative expenses is currently -$2.26 billion, with the most recent change of -$105.50 million (-4.90%) on 30 September 2024. Over the past year, it has dropped by -$2.30 billion (-5442.40%). CCCC TTM SG&A is now -1822.51% below its all-time high of $42.79 million, reached on 31 December 2022.CCCC TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CCCC Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -1.6% | +11.7% | -5442.4% |
| 3 y3 years | +176.8% | +39.2% | -7338.5% |
| 5 y5 years | +487.6% | +386.9% | -10000.0% |
CCCC Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -1.6% | +176.8% | -8.2% | +39.2% | -160.2% | at low |
| 5 y | 5 years | -1.6% | +487.6% | -8.2% | +386.9% | -1822.5% | at low |
| alltime | all time | -1.6% | +487.6% | -8.2% | +386.9% | -1822.5% | at low |
C4 Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $11.77 M(+21.4%) | $42.05 M(+3.0%) |
| June 2024 | - | $9.70 M(-5.8%) | $40.81 M(-1.5%) |
| Mar 2024 | - | $10.29 M(-0.1%) | $41.42 M(-1.6%) |
| Dec 2023 | $42.08 M(-1.7%) | $10.30 M(-2.2%) | $42.08 M(-0.5%) |
| Sept 2023 | - | $10.53 M(+2.2%) | $42.28 M(+2.3%) |
| June 2023 | - | $10.31 M(-5.8%) | $41.33 M(+1.0%) |
| Mar 2023 | - | $10.95 M(+4.3%) | $40.91 M(-4.4%) |
| Dec 2022 | $42.79 M(+28.7%) | $10.49 M(+9.6%) | $42.79 M(+4.2%) |
| Sept 2022 | - | $9.58 M(-3.2%) | $41.08 M(+2.8%) |
| June 2022 | - | $9.89 M(-22.8%) | $39.95 M(+3.3%) |
| Mar 2022 | - | $12.82 M(+46.0%) | $38.66 M(+16.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $33.25 M(+118.7%) | $8.78 M(+3.9%) | $33.25 M(+6.6%) |
| Sept 2021 | - | $8.45 M(-1.8%) | $31.20 M(+21.8%) |
| June 2021 | - | $8.61 M(+16.2%) | $25.61 M(+29.5%) |
| Mar 2021 | - | $7.41 M(+10.1%) | $19.77 M(+30.0%) |
| Dec 2020 | $15.20 M(+73.3%) | $6.73 M(+135.3%) | $15.20 M(+36.2%) |
| Sept 2020 | - | $2.86 M(+3.3%) | $11.16 M(+4.1%) |
| June 2020 | - | $2.77 M(-2.6%) | $10.72 M(+34.8%) |
| Mar 2020 | - | $2.84 M(+5.6%) | $7.95 M(+55.6%) |
| Dec 2019 | $8.77 M(+22.5%) | $2.69 M(+11.3%) | $5.11 M(+111.3%) |
| Sept 2019 | - | $2.42 M | $2.42 M |
| Dec 2018 | $7.16 M | - | - |
FAQ
- What is C4 Therapeutics annual selling, general & administrative expenses?
- What is the all time high annual SG&A for C4 Therapeutics?
- What is C4 Therapeutics annual SG&A year-on-year change?
- What is C4 Therapeutics quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for C4 Therapeutics?
- What is C4 Therapeutics quarterly SG&A year-on-year change?
- What is C4 Therapeutics TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for C4 Therapeutics?
- What is C4 Therapeutics TTM SG&A year-on-year change?
What is C4 Therapeutics annual selling, general & administrative expenses?
The current annual SG&A of CCCC is $42.08 M
What is the all time high annual SG&A for C4 Therapeutics?
C4 Therapeutics all-time high annual selling, general & administrative expenses is $42.79 M
What is C4 Therapeutics annual SG&A year-on-year change?
Over the past year, CCCC annual selling, general & administrative expenses has changed by -$708.00 K (-1.65%)
What is C4 Therapeutics quarterly selling, general & administrative expenses?
The current quarterly SG&A of CCCC is $11.77 M
What is the all time high quarterly SG&A for C4 Therapeutics?
C4 Therapeutics all-time high quarterly selling, general & administrative expenses is $12.82 M
What is C4 Therapeutics quarterly SG&A year-on-year change?
Over the past year, CCCC quarterly selling, general & administrative expenses has changed by +$1.24 M (+11.73%)
What is C4 Therapeutics TTM selling, general & administrative expenses?
The current TTM SG&A of CCCC is -$2.26 B
What is the all time high TTM SG&A for C4 Therapeutics?
C4 Therapeutics all-time high TTM selling, general & administrative expenses is $42.79 M
What is C4 Therapeutics TTM SG&A year-on-year change?
Over the past year, CCCC TTM selling, general & administrative expenses has changed by -$2.30 B (-5442.40%)